The Accenture Life Sciences practice helps companies pivot to the patient for best outcomes. See how we can help you. Visit https://accntu.re/2l5mUGu to learn more.

1. Patient Inspired. Outcomes Driven.
PIVOTTO
THEPATIENT

2. Successive waves of disruption
are reshaping healthcare – at
pace and magnitude.
RIDINGWAVES
OFDISRUPTION
Copyright © 2018 Accenture. All rights reserved. 2
In response to converging forces, life sciences is evol
ving rapidly from selling products at volume to
delivering value through better patient outcomes.
For those ready to seize the opportunity, it’s creating
infinite new possibilities to reinvent the patient
experience and redefine the future of healthcare.

3. FORCESOFCHANGE
INTODAY’S BUSINESSMODELS
Copyright © 2018 Accenture. All rights reserved. 3
Socio-economic
Trends
+
Healthcare
Consumerization
+
New Science
Landscape
Catalyzed by
Technology, Digital &
Data

4. Rise in healthcare outstripped rise in GDP by
55% in 2017 in US.*
Payors are demanding proof of improved
patient outcomes—value-based contracts
have nearly tripled since 2006.
THEECONOMICS
DON’TLINEUP
Copyright © 2018 Accenture. All rights reserved. 4
SOCIO-ECONOMICTRENDS
*Source: US Department of Commerce; Centers for Medicare & Medicaid Services

5. 5
WHY SHOULD
HEALTHISSUES
STOP ME FROM
LIVING MY
LIFE?
Patients now expect technology will help
them live a happy, fulfilled, ‘normal’ life,
despite their medical issues.
50% of millennials seek out care at on the go
retail locations.
HEALTHCARECONSUMERIZATION
Copyright © 2018 Accenture. All rights reserved.

6. Digital therapeutics are starting
to achieve outcomes comparable to
classical treatments—and they
aren’t just complementary to the
therapeutic—they are the therapeutic.
IT’SABRAVE
NEWWORLD
Copyright © 2018 Accenture. All rights reserved. 6
NEWSCIENCELANDSCAPE
This is paving the way to new science, new
markets and new business models.

7. Mapping the human genome enabled
breakthroughs in personalized
treatments where investment and
efficacy can be more certain.
Specialized medicines expected to
contribute to 52% of top 100 product
sales by 2024.*
Genomics expected to generate more
data than YouTube and other sources
by 2025.**
THISTIME
IT’SPERSONAL
Copyright © 2018 Accenture. All rights reserved. 7
NEWSCIENCELANDSCAPE
*Source EvaluatePharma World Preview 2017
**Source: Stephens, Zachary D., “Big Data: Astronical or Genomical;” PLoS Biology, 2015

8. 8
NEWTECH,
NEWWORLD
AI, IoT, cloud and wearables allow
for real-time data and insight. This creates
opportunities for entirely new business
models and “always” on patient care.
Copyright © 2018 Accenture. All rights reserved.

9. 9
…WITHDATA
INTHE
DRIVINGSEAT
Copyright © 2018 Accenture. All rights reserved.
Life sciences companies need to
grapple with big data sets
produced by many sources
including payers, health providers,
devices, and a host of other third
party data sources.

10. Copyright © 2018 Accenture. All rights reserved. 10
PERVASIVE
SENSORS/IoT
Health monitoring at point of need
Smart tattoos | Connected
clothing Digestible sensors
DATA
Genomic | EMR | Behavioral |
Lifestyle Nutritional
FASTER, CHEAPER,
CONNECTED
COMPUTING POWER
Private and Public Cloud | Limitless
data storage Quantum Computing
BLOCKCHAIN
Secure EMR | Digital clinical
trials Supply chain integrity/anti
counterfeiting | Patient services
ARTIFICIAL
INTELLIGENCE
RPA/Machine learning | Algorithms
Bots | Chatbots
AUTOMATED
DELIVERY/DRONES
Drones | Uber services
Autonomous vehicles
PERSONALIZED
SCIENCE
Genomic technologies | CRISPR
CarT | Nanobots | Digital pills
3D PRINTING/
MANUFACTURING IoT
Bioprinting - bones, tissues | Devices |
Proactive maintenance in manufacturing |
Lights-out factories | Connected,
responsive supply chains
LIVING
SERVICES
ANALYTICS
Prescriptive | Predictive | Cognitive
Visualization
THEPOWEROFDATAANDAI
CONVERGINGAROUNDTHEPATIENT

11. THETIMETO
EMBRACE
CHANGE
ISNOW.

12. FAST-CHANGING
COMPETITIVE
LANDSCAPE
The life sciences landscape
is getting fiercely competitive.
New players and digital entrants are
muscling in while incumbents are
repositioning to stay competitive.
Everyone wants a bigger share of the
healthcare value chain—with many
intent on fundamentally changing it.
Copyright © 2018 Accenture. All rights reserved. 12
DECEMBER
2017
JANUARY
2018
FEBRUARY
2018
MARCH
2018
APRIL
2018
+
+
+
+
+
+
+
+
+
+
JUNE
2018
+
+

13. Copyright © 2018 Accenture. All rights reserved. 13

14. WHOSEBETTINGON
NON-MOLECULARMEDICINE?
Copyright © 2018 Accenture. All rights reserved. 14
Six Example Deals & Relative Company Investment in Digital, Data and Genomics, Private
and Public funding Transactions 2007 — 2017 (Accenture Research Infographic)
DIGITAL DATA
GENOMICS
Biogen
95K – $400M
Sanofi Ventures – $400M
Otsuka – Collaboration
Harbin Gloria – $40M (JV) 2016
Many more
Roche
Sanofi Ventures
UCB
Amgen Ventures
Lilly
Novartis
Gementtry
Novo – $9M 2017
Pfizer – $9M 2017
JNJ
BMS
Celgene
Merck (MSD)
(Others as well non-pharma)
GRAIL
$900M
(Series B)
FLATIRON
$1.9B
Acquisition
AMRA MEDICAL
PROTEUS DIGITAL
HEALTH
VERILY
SCIENCE 37
*Source: Accenture Research, CBInsights, and Rock Health 2017 Investment Data

15. The opportunity to create
new value is up for grabs.
In the US, applying digital
to just six therapeutic areas
could deliver an economic
impact of $96B+.
THE
OPPORTUNITY
TORELEASE
TRAPPED
VALUE
Copyright © 2018 Accenture. All rights reserved. 15
$96.9B
potential
$60B+ risk adjusted potential*
$24B
Congestive
Heart Failure
6,325,226
US patients
$13.6B risk adjusted
$42B
Diabetes
38,260,665
US patients
$30.3B risk adjusted
$10B
Alzheimer’s
Disease
5,400,000
US patients
$6.2B risk adjusted
$9.7B
HIV
1,329,913
US patients
$4.8B risk adjusted
$7.5B
Breast Cancer
3,369,487
US patients
$2.8B risk adjusted
$4.7B
Multiple
Myeloma
148,728
US patients
$2.3B risk adjusted
*Source: “Digital Affectability: Therapeutic Lens on Value;” Accenture Research, 2017

16. WHOWILLYOUBEIN
THENEW?
ANDHOWWILL
YOUGETTHERE?

17. Copyright © 2018 Accenture. All rights reserved. 17
Patient
Do patients
love the
experience?
Paying entity
Do you drive value
for the payor and
whole system?
Health &
Wellness System
Do you drive value
by connecting all
pieces?
Enhanced
Product
Outcome
Focused
Platform
EconomyData
Platforms
Intelligence/AI
Tech
Digital Basics
Data
Platforms
CHOOSEYOURPATHTO
NEWMODELS
Science
Does the science
drive breakthrough
results?
Product

18. ROTATETO
THENEW
Copyright © 2018 Accenture. All rights reserved. 18
1. The timing, scale and direction
of investment are crucial –
transformation will be ongoing and
paced.
2. Traditional products will coexist with
specialized, digitally-enabled
science and services demanding a
modernized acquisition & growth
strategy.
3. The Wise Pivot is vital to protect your
core business while building new
outcomes-driven models where
the right partnerships are crucial.

19. Reimagine your core business to create new efficiencies
and unlock trapped value.
TRANSFORMYOURCORE
Copyright © 2018 Accenture. All rights reserved. 19Copyright © 2018 Accenture. All rights reserved. 19Copyright © 2018 Accenture. All rights reserved. 19
BECOME THE
MODERN
ENTERPRISE
Apply automation,
robotics, machine
learning and analytics
to accelerate and
improve R&D,
manufacturing
/supply, and access to
markets.
ACHIEVE
COMPETITIVE
AGILITY
Clarify value and
simplify systems.
Acquire and release
value to the core while
redefining your current
position in the
healthcare landscape.
EMBRACE
NEW IT
Adopt new tech and
analytics to make
better business
decisions that improve
patient care. Leverage
insights to enhance
your go-to-market
models.
TRANSFORM
FUNCTIONS
Consolidate and
strengthen your
therapeutic position,
while enabling cross-
functional scale and
connectivity via data,
digitization and your
portfolio strategy.

20. Invest in products and capabilities to create new value, using core strengths
to improve your competitive position and power better, faster innovations.
GROWYOURCORE
Copyright © 2018 Accenture. All rights reserved. 20Copyright © 2018 Accenture. All rights reserved. 20
USE APPLIED
INTELLIGENCE
Relentlessly pursue
value creation by
using new data-
driven insights and
analytics to inform
better, more timely,
streamlined
decisions.
BECOME A TRULY
LIVING BUSINESS
Create dominant
positions in select
therapies and/or
segments. Redefine
the new normal
patient and
customer drivers
and evolve to a
flexible personalized
service design.
EMBRACE
INDUSTRY X.0
Capitalize on the
digital reinvention of
industry via smart,
connected, ‘living’
tech to transform
your business and
accelerate
innovation.
SHAPE YOUR
FUTURE
WORKPLACE
Transform your
capabilities with
new talent, skills
and expertise to
enable a more
liquid, responsive
and innovative
future workforce.

21. Construct patient-centered, digitally enabled ecosystems, reaching new
markets via collaboration with traditional and non-healthcare players.
Copyright © 2018 Accenture. All rights reserved. 21
SCALEINTHENEW
ENHANCE
PRODUCTS
Apply intelligence
and services to the
scientific and
therapeutic model
across your value
chain to attract new
customers and
compete with new
entrants.
FOCUS ON
OUTCOMES
Reposition offerings
as outcomes-driven
programs. Compete
on portfolio vs
product metrics.
Share in value with
customers across
care pathways and
ecosystems.
LEVERAGE THE
PLATFORM ECONOMY
Drive value, grow
revenue, and build
competitive advantage
via new platform
offerings that scale and
cater to multiple
customers
simultaneously with a
system-lead strategy.

22. PATIENT
INSPIRED.
OUTCOMES
DRIVEN.
accenture.com/lifesciences